Basic information
Biomarker: ELR
Full name: Neutrophil-to-Lymphocyte Ratio
Clinical application: prognosis (unfavorable)
Histology type: endometrial carcinoma
Cohort characteristics
Followed up time : 54.8 (range 24.6-58.4)
Cohort age: 74;89
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 163 | ELR <0.1 | 117 | ELR >= 0.1 | 46 |
Sample information
Sample type : serum
Expression pattern : upregulated
Biomarker characteristic: >=0.1
Disease information
Subgroup 1 name: ELR <0.1
Subgroup 2 name: ELR >= 0.1
Subgroup 2 number: 46
